Literature DB >> 24939860

Clinical Practice Guidelines on diagnosis and treatment of hyponatraemia: response to letter from Otsuka Ltd.

Wim Van Biesen1, Raymond Vanholder2.   

Abstract

Mesh：

Year:  2014        PMID： 24939860     DOI： 10.1530/EJE-14-0393

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


× No keyword cloud information.
  5 in total

Review 1.  [Hyponatremia in emergency admissions - often dangerous].

Authors:  W Fenske
Journal:  Internist (Berl)       Date:  2017-10       Impact factor: 0.743

2.  [Hyponatremia and tolvaptan : what is the situation 5 years after approval?].

Authors:  J Hensen
Journal:  Internist (Berl)       Date:  2015-07       Impact factor: 0.743

Review 3.  Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.

Authors:  Ewout J Hoorn; Robert Zietse
Journal:  J Am Soc Nephrol       Date:  2017-02-07       Impact factor: 10.121

4.  Prognosis of patients with severe hyponatraemia is related not only to hyponatraemia but also to comorbidities and to medical management: results of an observational retrospective study.

Authors:  Thierry Krummel; Eric Prinz; Marie-Astrid Metten; Claire Borni-Duval; Dorothée Bazin-Kara; Emmanuelle Charlin; Jean-Marc Lessinger; Thierry Hannedouche
Journal:  BMC Nephrol       Date:  2016-10-22       Impact factor: 2.388

5.  The Clinical Practice Guideline on diagnosis and treatment of hyponatraemia: a response from Otsuka Pharmaceutical Europe Ltd.

Authors:  Marco Avila
Journal:  Eur J Endocrinol       Date:  2014-07       Impact factor: 6.664
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.